MeiraGTx Holdings plc Finance Lease, Principal Payments
MeiraGTx Holdings plc (MGTX) reported Finance Lease, Principal Payments of $29.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-13
- MeiraGTx Holdings plc finance lease, principal payments for the quarter ending 2026-06-30 was $15.00K.
- MeiraGTx Holdings plc finance lease, principal payments for the quarter ending 2026-03-31 was $14.00K.
- MeiraGTx Holdings plc finance lease, principal payments for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- MeiraGTx Holdings plc finance lease, principal payments for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- MeiraGTx Holdings plc finance lease, principal payments for fiscal 2025 was $29.00K.
- MeiraGTx Holdings plc finance lease, principal payments for fiscal 2021 was $1.00K, a 95.65% decline from fiscal 2020.
- MeiraGTx Holdings plc finance lease, principal payments for fiscal 2020 was $23.00K, a 7.47% decline from fiscal 2019.
- MeiraGTx Holdings plc finance lease, principal payments for fiscal 2019 was $24.86K, a 19.43% decline from fiscal 2018.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 3 month as first filed | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 6 month as first filed | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 9 month as first filed | Finance Lease, Principal Payments 12 month | Finance Lease, Principal Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $29.00K 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | $14.00K 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | $29.00K 10-K · filed 2026-03-30 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | -$4.00K derived: sum of 3 quarters · filed 2023-03-14 | $1.00K 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$4.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.00K 10-Q · filed 2022-11-10 | $5.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.00K 10-Q · filed 2022-08-11 | $5.00K derived: sum of 3 quarters · filed 2022-08-11 | $8.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-12 | $9.00K derived: sum of 2 quarters · filed 2022-05-12 | $12.00K derived: sum of 3 quarters · filed 2022-05-12 | $18.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $7.00K derived: sum of 2 quarters · filed 2022-03-10 | $13.00K derived: sum of 3 quarters · filed 2022-03-10 | $23.00K 10-K · filed 2022-03-10 | $23.05K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $9.00K derived: sum of 2 quarters · filed 2021-11-10 | $19.00K 10-Q · filed 2021-11-10 | $19.34K 10-Q · filed 2020-11-05 | $25.93K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $16.00K 10-Q · filed 2021-08-11 | $15.88K 10-Q · filed 2020-08-06 | $22.93K derived: sum of 3 quarters · filed 2021-08-11 | $27.49K derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $10.00K 10-Q · filed 2021-05-11 | $842.00 10-Q · filed 2020-05-07 | $16.93K derived: sum of 2 quarters · filed 2021-05-11 | $21.49K derived: sum of 3 quarters · filed 2021-05-11 | $34.30K derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $6.93K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $11.49K derived: sum of 2 quarters · filed 2021-03-11 | $24.30K derived: sum of 3 quarters · filed 2021-03-11 | $24.86K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $4.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $17.37K derived: sum of 2 quarters · filed 2020-11-05 | $17.92K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $12.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.37K 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $553.00 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $30.85K 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |